Product logins

Find logins to all Clarivate products below.


Dr. Srikanth Rajagopal

Managing Partner and Vice President, Commercial Consulting Services

Doc is an experienced management consultant, client partner and practice leader, with close to 20 years of experience selling, leading & delivering a range of product and portfolio strategy, transaction advisory, evidence generation, pricing and market access, commercial strategy and transformation, and business innovation engagements for biopharmaceutical industry clients and their investors across the US, Europe, Asia-Pacific and Japan.​

He believes in a structured, collaborative, expertise-based approach to problem-solving and solution development. Doc partners with colleagues across Clarivate to harness our deep expertise in global healthcare systems, policy, drug development and approval, therapy areas and indications, business development and licensing, pricing and reimbursement systems and processes, customer engagement models and data and advanced analytics to deliver exceptional, impactful outcomes for our clients.​

He previously led Clarivate Europe, Asia-Pacific and Japan Commercial Consulting business, and has held positions of increasing responsibility at global consulting firms such as Guidehouse, IQVIA and Strategic Decisions Group (SDG).

By way of academic qualifications, Doc holds an MBA from the Indian Institute of Management, Ahmedabad and an MBBS (MD equivalent) from the University of Mumbai.


arrow_forward
Get in touch with Srikanth

Related resources

生物制药领域中隐藏于公开信息中的竞争信号 生物制药领域中隐藏于公开信息中的竞争信号
Blog June 24, 2026
生物制药领域中隐藏于公开信息中的竞争信号
在生命科学领域部署代理式 AI 的五大经验教训 在生命科学领域部署代理式 AI 的五大经验教训
Blog June 16, 2026
在生命科学领域部署代理式 AI 的五大经验教训
AI/机器学习
支付方愿意为便利性买单的市场准入“最佳切入点” 支付方愿意为便利性买单的市场准入“最佳切入点”
Blog June 3, 2026
支付方愿意为便利性买单的市场准入“最佳切入点”
医疗保险 定价 市场准入 真实世界数据 美国市场 药政法规
一种药物,七个名称:药物竞争情报数据背后隐藏的复杂性 一种药物,七个名称:药物竞争情报数据背后隐藏的复杂性
Blog June 2, 2026
一种药物,七个名称:药物竞争情报数据背后隐藏的复杂性
市场准入 案例研究 药政法规